Graft-versus-host disease therapy (ASC therapeutics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGraft-versus-host disease therapy (ASC therapeutics)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsGraft vs Host Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesApplied Stemcell
China Registration ClassN/A

Develop Information

Active CompaniesApplied Stemcell
Inactive CompaniesN/A
Active IndicationsGraft vs Host Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A